Furthermore, knockdown of EXT1 not only repressed cancer cell stemness but also downregulated EMT markers and abolished cell surface HS, suggesting EXT1 as a potential molecular target to overcome cancer cell stemness in doxo-mediated therapeutic resistance. The gene discussed is EXT1; the disease is cancer.